Cardinal Manufacturing Helped By FDA Compliance Crackdown, Firm Says
Executive Summary
FDA's crackdown on pharmaceutical GMP compliance is expanding the outsourcing opportunities for contract manufacturers, Cardinal Health Life Sciences Products & Services President George Fotiades told the J.P. Morgan H&Q conference in San Francisco Jan. 7
You may also be interested in...
Cardinal Management In Sync: Parrish To Head Distribution After Syncor Deal
Cardinal's drug distribution business will be led by Mark Parrish after a management reshuffling triggered by the acquisition of Syncor
FDA Part 11 Policy Should Take Risk-Based Approach, PhRMA Says
FDA should revise its draft guidance on electronic records to take a risk-based approach that is in line with the agency's GMP initiative, PhRMA said in comments on FDA's Part 11 draft guidance
Cardinal Management In Sync: Parrish To Head Distribution After Syncor Deal
Cardinal's drug distribution business will be led by Mark Parrish after a management reshuffling triggered by the acquisition of Syncor